- Home
- EH vs SPRY Comparison
EH vs SPRY Comparison
Compare EH & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EH
- SPRY
- Stock Information
- Founded
- EH 2014
- SPRY 2015
- Country
- EH China
- SPRY United States
- Employees
- EH N/A
- SPRY N/A
- Industry
- EH Military/Government/Technical
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- EH Industrials
- SPRY Health Care
- Exchange
- EH Nasdaq
- SPRY Nasdaq
- Market Cap
- EH 1.5B
- SPRY 1.2B
- IPO Year
- EH 2019
- SPRY N/A
- Fundamental
- Price
- EH $20.75
- SPRY $12.49
- Analyst Decision
- EH Buy
- SPRY Strong Buy
- Analyst Count
- EH 1
- SPRY 4
- Target Price
- EH $27.50
- SPRY $28.75
- AVG Volume (30 Days)
- EH 2.0M
- SPRY 2.0M
- Earning Date
- EH 03-12-2025
- SPRY 03-20-2025
- Dividend Yield
- EH N/A
- SPRY N/A
- EPS Growth
- EH N/A
- SPRY N/A
- EPS
- EH N/A
- SPRY 0.08
- Revenue
- EH $62,494,280.00
- SPRY $89,149,000.00
- Revenue This Year
- EH N/A
- SPRY $41.49
- Revenue Next Year
- EH $59.77
- SPRY $80.23
- P/E Ratio
- EH N/A
- SPRY $156.13
- Revenue Growth
- EH 288.46
- SPRY 297063.34
- 52 Week Low
- EH $10.40
- SPRY $7.55
- 52 Week High
- EH $29.76
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- EH 42.16
- SPRY 53.51
- Support Level
- EH $21.81
- SPRY $12.08
- Resistance Level
- EH $23.44
- SPRY $13.22
- Average True Range (ATR)
- EH 1.60
- SPRY 0.91
- MACD
- EH -0.38
- SPRY 0.12
- Stochastic Oscillator
- EH 11.27
- SPRY 41.07
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.